| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |